Company Statement: Sanofi-aventis - Statement on Genzyme discussions
MLex Summary: French pharmaceuticals company Sanofi-aventis is in discussions with Genzyme over the value of one of the target company's drugs.Paris, France - January 9, 2011 - Sanofi-aventis (EURONEXT: SAN and...To view the full article, register now.
Already a subscriber? Click here to view full article